Orange Book product · Generic (ANDA)
TIOPRONIN
TIOPRONIN
At a glance
Feb 24, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 24, 2023
3 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
TIOPRONIN
Strength
100MG
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 217219
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TIOPRONIN
- 2019THIOLA ECBrand (NDA)
NDA 211843 · MISSION PHARMACAL
- 1988THIOLABrand (NDA)
NDA 019569 · MISSION PHARMA
- 2025TIOPRONINGeneric (ANDA)
ANDA 216278 · AMNEAL
- 2024TIOPRONINGeneric (ANDA)
ANDA 216456 · TEVA PHARMS INC
- 2024VENXXIVAGeneric (ANDA)
ANDA 216990 · TORRENT
- 2022TIOPRONINGeneric (ANDA)
ANDA 216198 · PH HEALTH
- 2021TIOPRONINGeneric (ANDA)
ANDA 214326 · TEVA PHARMS USA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
